Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Public ClinicalTrials.gov record NCT03154190. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
St. Judes-Stanford Comprehensive Support Initiative
Study identification
- NCT ID
- NCT03154190
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Stanford University
- Other
- Enrollment
- 128 participants
Conditions and interventions
Conditions
- Acute Myeloid Leukemia
- Brain Glioblastoma
- Estrogen Receptor Negative
- Extensive Stage Small Cell Lung Carcinoma
- HER2/Neu Negative
- Head and Neck Carcinoma
- Hormone-Resistant Prostate Cancer
- Limited Stage Small Cell Lung Carcinoma
- Myelodysplastic Syndrome
- Progesterone Receptor Negative
- Progressive Disease
- Recurrent Carcinoma
- Stage II Pancreatic Cancer
- Stage II Rectal Cancer
- Stage IIA Pancreatic Cancer
- Stage IIA Rectal Cancer
- Stage IIB Pancreatic Cancer
- Stage IIB Rectal Cancer
- Stage IIC Rectal Cancer
- Stage III Colon Cancer
- Stage III Esophageal Cancer
- Stage III Gastric Cancer
- Stage III Non-Small Cell Lung Cancer
- Stage III Ovarian Cancer
- Stage III Pancreatic Cancer
- Stage III Rectal Cancer
- Stage III Skin Melanoma
- Stage IIIA Colon Cancer
- Stage IIIA Esophageal Cancer
- Stage IIIA Gastric Cancer
- Stage IIIA Non-Small Cell Lung Cancer
- Stage IIIA Ovarian Cancer
- Stage IIIA Rectal Cancer
- Stage IIIA Skin Melanoma
- Stage IIIB Colon Cancer
- Stage IIIB Esophageal Cancer
- Stage IIIB Gastric Cancer
- Stage IIIB Non-Small Cell Lung Cancer
- Stage IIIB Ovarian Cancer
- Stage IIIB Rectal Cancer
- Stage IIIB Skin Melanoma
- Stage IIIC Colon Cancer
- Stage IIIC Esophageal Cancer
- Stage IIIC Gastric Cancer
- Stage IIIC Ovarian Cancer
- Stage IIIC Rectal Cancer
- Stage IIIC Skin Melanoma
- Stage IV Bladder Cancer
- Stage IV Bone Sarcoma
- Stage IV Breast Cancer
- Stage IV Colon Cancer
- Stage IV Esophageal Cancer
- Stage IV Gastric Cancer
- Stage IV Non-Small Cell Lung Cancer
- Stage IV Ovarian Cancer
- Stage IV Pancreatic Cancer
- Stage IV Rectal Cancer
- Stage IV Renal Cell Cancer
- Stage IV Skin Melanoma
- Stage IV Soft Tissue Sarcoma
- Stage IVA Bone Sarcoma
- Stage IVA Colon Cancer
- Stage IVA Rectal Cancer
- Stage IVB Bone Sarcoma
- Stage IVB Colon Cancer
- Stage IVB Rectal Cancer
- Triple-Negative Breast Carcinoma
Interventions
- Best Practice Other
- Laboratory Biomarker Analysis Other
- Supportive Care Procedure
- Survey Administration Other
Other · Procedure
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 7, 2017
- Primary completion
- Nov 29, 2021
- Completion
- Aug 29, 2022
- Last update posted
- Jan 23, 2025
2017 – 2022
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Virginia K Crosson Cancer Center | Fullerton | California | 29835 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03154190, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 23, 2025 · Synced May 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03154190 live on ClinicalTrials.gov.